Artigo · Revista · 2021

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

Alfred Olaoluwa Akinlalu, Annapoorna Chamundi, Donald Terseer Yakumbur, Funmilayo Ibitayo Deborah Afolayan, Ijeoma A. Duru, Michael Arowosegbe e mais 1

Scientific African

• Acesso aberto · Dourado
• Internacional · 2 países

Lê-lo10.1016/j.sciaf.2021.e00845